Individualising goal-directed haemodynamic therapy: future iterations will require novel trial designs

Area of Science:

• Anesthesiology
• Critical Care Medicine
• Cardiovascular Physiology

Background:

• Perioperative cardiac output-guided haemodynamic therapy algorithms have been evaluated for decades.
• Existing evidence for the effectiveness of these algorithms remains inconclusive.

Discussion:

• Recent strategies focus on individualizing physiological targets, moving beyond generic algorithms.
• Early efficacy trials of these newer approaches are underway, but significant uncertainty persists regarding their clinical benefits.
• The complexity of this intervention poses challenges for traditional clinical trial designs.

Key Insights:

• Despite extensive research, the definitive benefits of cardiac output-guided haemodynamic therapy are not established.
• Individualized physiological targets represent a promising, yet unproven, advancement in hemodynamic management.
• Current evidence is insufficient to support widespread adoption.

Outlook:

• Novel clinical trial designs are crucial to overcome the limitations of smaller studies.
• Accelerating the exploration of future developments in hemodynamic therapy is essential.
• Further research is needed to clarify the role and optimal application of advanced hemodynamic monitoring and guidance.